Aileron Therapeutics Inc
(NAS:ALRN)
$
2.84
0.08 (2.9%)
Market Cap: 61.31 Mil
Enterprise Value: 44.05 Mil
PE Ratio: 0
PB Ratio: 1.07
GF Score: 42/100 Aileron Therapeutics Inc (ALRN) Transcripts
- Aileron Therapeutics Inc M&A Call TranscriptOct 31, 2023
- Aileron Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual)- Pre-recorded TranscriptSep 12, 2022
- Aileron Therapeutics Inc Phase 1b Non-Small Cell Lung Cancer Interim Analysis Conference Call TranscriptJun 29, 2022
- Aileron Therapeutics Inc at Emerging Growth Conference TranscriptJan 05, 2022
- Aileron Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Q3 2019 Aileron Therapeutics Inc Earnings Call TranscriptNov 07, 2019$10.4 (-7.70%)Earnings
- 1